G Meloni
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 10
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 7
- Multiple Myeloma Research and Treatments 2
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 4
- Rheumatology top 10%
-
- Acute Lymphoblastic Leukemia research 3
-
- Lymphoma Diagnosis and Treatment 2
-
- Testicular diseases and treatments 1
- Co-authors
- Giuseppe SaglioFabrizio PaneBruno RotoliF. FerraraFrancesco SalvatoreFerdinando FrigeriLuigia LucianoFranco Mandelli
- Cited by
- HematologyGeneticsRheumatology
- Journals
- Blood (2 papers)Bone Marrow Transplantation (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- ItalyFranceUnited Kingdom
In The Last Decade
G Meloni
24 papers receiving 522 citations
Peers
Comparison fields: 5 of 53
- Hematology 461
- Genetics 268
- Rheumatology 118
- Public Health, Environmental and Occupational Health 99
- Pathology and Forensic Medicine 57
Countries citing papers authored by G Meloni
This map shows the geographic impact of G Meloni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Meloni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Meloni more than expected).
Fields of papers citing papers by G Meloni
This network shows the impact of papers produced by G Meloni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Meloni. The network helps show where G Meloni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G Meloni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgaris. | 2014 | 38 |
| 2 | A SEQUENTIAL USE OF TKI, CHEMOTHERAPY AND TRANSPLANT IS ASSOCIATED WITH HIGH COMPLETE REMISSION RATES, DISEASE-FREE AND OVERALL SURVIVAL IN ADULT PH+ ALL. RESULTS OF THE GIMEMA 0904 PROTOCOL | 2013 | 1 |
| 3 | 2003 | 20 | |
| 4 | Dose intensification with autologous stem cell transplantation in relapsed and resistant Hodgkin's disease. | 2002 | 3 |
| 5 | Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia | 1999 | 2 |
| 6 | 1999 | 30 | |
| 7 | Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo. | 1999 | 30 |
| 8 | Autologous peripheral blood stem cell transplantation in a patient with multiple sclerosis and concomitant Ph+ acute leukemia. | 1999 | 15 |
| 9 | 1996 | 257 | |
| 10 | 1995 | 3 | |
| 11 | Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in remission: first choice for isolated extramedullary relapse? | 1994 | 9 |
| 12 | Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT. | 1994 | 45 |
| 13 | Autologous transplantation in chronic myelogenous leukemia: European results: Chronic Leukemia Working Party of the EBMT. | 1994 | 5 |
| 14 | Allogeneic vs autologous BMT vs intensive chemotherapy in childhood AnLL during first complete remission: AIEOP experience. AIEOP Cooperative Group. | 1991 | 2 |
| 15 | Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia. | 1991 | 12 |
| 16 | Evaluation of late side-effects after bone marrow transplantation in children with leukemia. | 1991 | 9 |
| 17 | Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion. | 1990 | 12 |
| 18 | Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission. | 1989 | 6 |
| 19 | Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission. | 1989 | 23 |
| 20 | High-dose chemotherapy and autologous stem cell infusion in patients with chronic myelogenous leukaemia in early phase of the disease | 1988 | 3 |
About G Meloni
G Meloni is a scholar working on Hematology, Genetics and Biochemistry, having authored 24 papers that have together received 547 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (10 papers), Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (7 papers), Chronic Lymphocytic Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Multiple Myeloma Research and Treatments (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Testicular diseases and treatments (1 paper). The work is most often cited by research in Hematology (461 citations), Genetics (268 citations) and Rheumatology (118 citations). G Meloni has collaborated with scholars based in Italy, France and United Kingdom. Frequent co-authors include Giuseppe Saglio, Fabrizio Pane, Bruno Rotoli, F. Ferrara, Francesco Salvatore, Ferdinando Frigeri, Luigia Luciano, Franco Mandelli, Josy Reiffers and J M Goldman. Their work appears in journals such as Blood, Bone Marrow Transplantation, British Journal of Haematology, Acta Haematologica and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.